Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Kansas school officials report high student illness, dismiss early - 2One dead, six wounded in various crime-related shootings in Israel over the weekend
- 3Hypothermia claims newborn in Gaza and more babies are at risk, doctor says
- 4How stripping diversity, equity and inclusion from health care may make Americans sicker
- 5Iranian missile hit on Ne'ot Hovav factory leads to fear of chemical leakage
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- New Gaza militia declares war on Hamas: 'Your dirty shoes are more honorable'
- Israeli tourist data from 2025 misrepresented as mass exodus to Thailand
- How federal officials talk about health is shifting in troubling ways – and that change makes me worried for my autistic child
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- A trip to Colombia in my 20s turned into 8 years freelancing in South America. Here's what I'd do differently.
- 25 Most Beautiful Villages in France You Can Actually Visit
- Asia's Noteworthy Destinations: A Voyager's Aide
- How many ships have been attacked in the Gulf since start of Iran war?
